Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)
Clinical trial NCT00549757 · TERMINATED
Trial details
- NCT number
- NCT00549757
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2013-02-01
- Enrollment
- 8606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.